Prevalence of end of treatment RNA-positive/sustained viral response in HCV patients treated with sofosbuvir combination therapies

BACKGROUND: Some chronic hepatitis C virus (HCV), genotype 1 infected patients treated with direct antiviral agents (DAAs) remain viremic at end of treatment (EOT+), yet go on to achieve sustained virological response 12 weeks after completion of therapy (SVR(12)). The incidence of EOT+/SVR in patie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Therap Adv Gastroenterol
Hauptverfasser: Malespin, Miguel, Benyashvili, Tamara, Uprichard, Susan L., Perelson, Alan S., Dahari, Harel, Cotler, Scott J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: SAGE Publications 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5330612/
https://ncbi.nlm.nih.gov/pubmed/28286560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X16672392
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge